Occurrence of pharmaceuticals and personal care products in bottled water and assessment of the associated risks

• Main Authors: Chengfei Wang, Dongyang Ye, Xiaowei Li, Yanbo Jia, Liang Zhao, Saiwa Liu, Jian Xu, Jingjing Du, Lu Tian, Jing Li, Jianzhong Shen, Xi Xia
• Format: Article
• Language: English
• Published: Elsevier 2021-10-01
• Series: Environment International
• Subjects: Pharmaceuticals and personal care products; Bottled water; Health risk assessment; Residue
• Online Access: http://www.sciencedirect.com/science/article/pii/S0160412021002762

The occurrence of 187 pharmaceuticals and personal care products (PPCPs) was investigated in bottled water samples (35 and 33 from Chinese and foreign brands, respectively). Forty-four compounds belonging to 14 PPCP categories were detected in 56 of the 68 bottled water samples. Further, more than 35% of water samples contained at least three PPCPs, and in one particular sample, 11 different PPCPs were detected. Macrolides constituted the most prevalent PPCP category, and salbutamol, erythromycin, and azithromycin showed the highest detection frequency (17.6%). The thermal stabilities of the 187 PPCPs were determined, and the results obtained showed that only 35 out of the 187 compounds were degraded by more than 50% after boiling for 5 min. Even though the risk quotients (RQs) of detected PPCPs showed low risk levels, the RQs of 13 compounds with RQs ≥ 0.0001 were 2–4 fold higher in infants than in other life stages. Moreover, further studies are necessary to evaluate the toxicity of PPCP mixtures, the effects of PPCPs on human intestinal microbiota, and their risk of induction of drug-resistant bacteria and drug-resistant genes.